NASDAQ · Medical - Devices

Establishment Labs Holdings Inc. (ESTA) Stock

$63.80 +0.44% NASDAQ: ESTA Healthcare

Valuation

MetricValue
Price$63.80
Market Cap$1.90B
P/E Ratio-48.96
P/B Ratio89.30
P/S Ratio7.67
EPS (TTM)$-1.72
52-Week High$97.59
52-Week Low$38.38
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-203.88%
ROA-11.05%
ROCE-6.53%
Gross Margin-18.48%
Operating Margin-18.48%
Net Margin-15.82%
Debt/Equity12.20
Current Ratio3.05

Annual Financials (USD)

Metric20212022202320242025
Revenue$127.0M$162.0M$165.0M$166.0M$211.0M
Operating Profit$-25.0M$-40.0M$-65.0M$-50.0M$-39.0M
Net Profit$-41.0M$-75.0M$-79.0M$-85.0M$-51.0M
EPS$-1.72$-3.08$-3.07$-3.00$-1.72
Op Margin-19.8%-24.5%-39.4%-30.1%-18.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$140.0M$211.0M$269.0M$347.0M$357.0M
Total Liabilities$89.0M$219.0M$250.0M$294.0M$334.0M
Cash$53.0M$66.0M$40.0M$90.0M$76.0M
Borrowings$54.0M$179.0M$192.0M$225.0M$264.0M

Latest News

A Hedge Fund Dumped Establishment Labs Shares Worth $6.6 Million. Here's a Closer Look at the Transaction. Motley Fool · Jul 5, 2026 Establishment Labs® Appoints Taylor Harris to Board of Directors Business Wire · Jun 29, 2026 Establishment Labs® Added to Membership of U.S. Small-Cap Russell 2000® Index Business Wire · Jun 25, 2026 Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy? Motley Fool · May 30, 2026 Route 92 Medical Announces Appointment of Raj Denhoy as Chief Financial Officer GlobeNewswire · May 18, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-28.0M$-52.0M$-89.0M$-59.0M$-51.0M
Investing Cash Flow$-14.0M$-69.0M$-49.0M$-31.0M$-14.0M
Financing Cash Flow$0$0$2.0M$2.0M$-1.0M
Net Cash Flow$-31.0M$13.0M$-26.0M$50.0M$-15.0M
Free Cash Flow$-34.0M$-86.0M$-113.0M$-74.0M$-58.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.54
EV / EBITDA-310.40
FCF Yield-2.23%
Quick Ratio2.52
Interest Coverage-0.68
Return 1Y115.94%
Return 3Y33.36%
Return 5Y23.12%

Ownership

Insiders Held10.15%
Institutions Held102.82%
Institutions Float Held114.44%
Institutional HolderSharesReport Date
JW Asset Management, LLC3,061,6942026-03-31
RTW Investments LP2,655,6952026-03-31
Brown Advisory Inc.1,526,8722026-03-31
Tyro Capital Management LLC1,151,3092026-03-31
Findell Capital Management LLC997,7472026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
IARTIntegra LifeSciences Holdings Corporation $11.91 -3.37% -176.57 $926.27M 0.00%
INMDInMode Ltd. $13.97 -0.57% 11.27 $803.89M 0.00%
TELATELA Bio, Inc. $0.97 -4.46% -1.42 $43.56M 0.00%

About Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc. (ESTA) stock trades at $63.80 with a market capitalization of $1.90B. The stock is valued at a negative price-to-earnings (P/E) ratio of -48.96, reflecting a net loss over the last twelve months, price-to-book of 89.30, price-to-sales of 7.67. Over the past 52 weeks the stock has ranged between $38.38 and $97.59, and currently trades 34.6% below its 52-week high.

On profitability, Establishment Labs Holdings Inc. generates a return on equity (ROE) of -203.88% (negative, reflecting a net loss), return on capital employed of -6.53%, an operating margin of -18.48%, a net profit margin of -15.82%.

Establishment Labs Holdings Inc. by the numbers, 2016–2025

Between 2016 and 2025 Establishment Labs Holdings Inc. reported revenue of $20.0M rising to $211.0M, a change of +955.0% across 10 years. Compounded, revenue has grown 19.9% a year over five years, 9.2% over three, 27.1% over the last twelve months. Net profit fell to $-51.0M.

Operating margin went from -80.0% in 2016 to -18.5% in 2025, a gain of 61.5 percentage points. The most recent net margin is -15.82%. On a trailing twelve-month basis to Jun '26, revenue is $247.0M and net profit $-39.0M.

Borrowings rose from $38.0M to $264.0M, cash from operations was $-51.0M in the latest year, positive in 0 of the last 10.

Return on equity has averaged 9.1% over five years, and was -212.5% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Establishment Labs Holdings Inc. (ESTA) — frequently asked questions

What is Establishment Labs Holdings Inc. (ESTA) stock price today?

Establishment Labs Holdings Inc. (ESTA) is currently trading at $63.80, up 0.44% today.

What is ESTA P/E ratio?

Establishment Labs Holdings Inc.'s P/E ratio is -48.96. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is ESTA return on equity (ROE)?

Establishment Labs Holdings Inc.'s return on equity (ROE) is -203.88%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Establishment Labs Holdings Inc.'s market cap?

Establishment Labs Holdings Inc. has a market capitalization of $1.90B.

Does ESTA pay a dividend?

Establishment Labs Holdings Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does ESTA carry?

Establishment Labs Holdings Inc. has a debt-to-equity ratio of 12.20. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is ESTA's profit margin?

Establishment Labs Holdings Inc. reports a net profit margin of -15.82% — the share of revenue left after every cost, including tax and interest.

What sector is ESTA in?

Establishment Labs Holdings Inc. is classified under Healthcare, in the Medical - Devices industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is ESTA listed on?

Establishment Labs Holdings Inc. trades on NASDAQ under the ticker ESTA.

What is ESTA's 52-week range?

Over the last year Establishment Labs Holdings Inc. has traded between $38.38 and $97.59.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens ESTA currently matches

On the figures above, Establishment Labs Holdings Inc. passes the filters for 5 of our ready-made screens, among them Small Cap Stocks, Most Shorted Stocks, High Debt to Equity Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Small Cap StocksMost Shorted StocksHigh Debt to Equity StocksStocks Under $100High Current Ratio Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.